About: Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1999 (uk) 1999 ജൂണ്‍ 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം (ml) article scientifique publié en 1999 (fr) im Juni 1999 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q59780771-CC1EC8FF-73C1-4182-913B-76B5F788A036
publication date	1999-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59780771-F1FB1A87-4A75-4C56-8940-619DE5B69F1F
language of work or name	English
author name string	wds:Q59780771-0381CE2A-B097-4F97-9FAB-39E54DDE292C wds:Q59780771-0A977B2F-3D26-42D4-92D2-AFB046BA6298 wds:Q59780771-76B3E20D-82F8-4C0D-B8A4-60D0D56ABAF5 wds:Q59780771-B7AD3CC9-7A9D-4DF5-9A24-9F10D70E368C wds:Q59780771-C188CA47-74B4-4AC3-ABE0-FCCCC422EAEE wds:Q59780771-D5760254-13A6-4553-8D3F-A3A299969BE9 wds:Q59780771-DE73336C-C639-4AAB-8AEA-370483089269 wds:Q59780771-F0597261-EF68-47A3-8175-5BB3FEFF8141 wds:Q59780771-F0CEC913-BAE9-4288-A5C1-649C315D32F4
author name string	A Salas E Torres J Alvar J Sanz J Torre-Cisneros J Gómez-Rodrigo F Laguna G Picó R López-Vélez
rdfs:label	Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B (en) Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B (nl)
skos:prefLabel	Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B (en) Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B (nl)
name	Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B (en) Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B (nl)
author	wds:Q59780771-007E9022-5B89-421D-A635-A38F1E4E8B1E wds:Q59780771-1A484C4E-CE43-4C92-B866-FA35C136BF86 wds:Q59780771-41E83DAD-839B-42A9-80B9-E09533FE8FC5
author	Federico Pulido Juan Pasquau F J Medrano
title	wds:Q59780771-30AD8273-60FA-407A-BE69-EDF4CE4CA27E
title	Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group (en)
page(s)	wds:Q59780771-9E8E52A1-D300-44FA-9586-D4DD5A45E6B3
page(s)	1063-1069
instance of	wds:Q59780771-EDD12204-181D-417C-ABFC-7FA2564D5952
instance of	scholarly article
main subject	wds:Q59780771-32B9EF35-42AB-4528-8209-DBB2DC4BC408 wds:Q59780771-3B86EAC8-4DF7-4252-9AB1-8F08B15D7E2F wds:Q59780771-7097E528-F5E4-4E67-A90A-49BCC95432B0
main subject	meglumine antimoniate visceral leishmaniasis amphotericin B
PubMed ID	wds:Q59780771-A5590BD5-C580-46EA-A5F9-2F556E7FAB7C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10397536
PubMed ID	10397536
published in	wds:Q59780771-B50CDDF7-005D-479E-966B-9560401029AB
published in	AIDS
issue	wds:Q59780771-A8E8801F-6163-49B4-9196-118C641E5562
volume	wds:Q59780771-F7F0CFE3-F510-4FF7-89ED-964C5DA717EA
issue	9
volume	13
DOI	wds:Q59780771-F3A0508E-3F72-4DA1-B2DD-964915678F9D
DOI	http://dx.doi.org/10.1097/00002030-199906180-00009
DOI	10.1097/00002030-199906180-00009
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59780771
is cites work of	Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Drug resistance in leishmaniasis Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India Interventions for Old World cutaneous leishmaniasis Chemotherapy in the treatment and control of leishmaniasis Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region The relationship between leishmaniasis and AIDS: the second 10 years Clinical and experimental advances in treatment of visceral leishmaniasis Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral miltefosine A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus. Leishmaniasis Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches Human immunodeficiency virus and leishmaniasis Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison Therapeutic options for visceral leishmaniasis Leishmaniasis The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections. Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana. Intestinal leishmaniasis in acquired immunodeficiency syndrome. Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal Visceral leishmaniasis in renal transplant recipients: clinical aspects, diagnostic problems, and response to treatment Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide Visceral leishmaniasis associated with human immunodeficiency virus infection Unusual duodenal presentation of leishmaniasis Interventions for Old World cutaneous leishmaniasis Leishmaniasis Treatment With Liposomal Amphotericin B for All Confirmed Cases of Human Visceral Leishmaniasis in Brazil: A Budget Impact Analysis Visceral leishmaniasis and HIV coinfection in the Mediterranean region.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software